Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

January
05
2021

What Are the Symptoms of Skin Cancer?

Skin Cancer Shows Up in Many Different Ways, Which Is Why It’s Dangerously Easy to Miss Skin cancer will afflict roughly one in four Americans, so for millions of us, it’s not a matter of…

January
05
2021

Superficial Radio Therapy for Skin Cancer Treatment in Maine

How Common is Skin Cancer in Maine? Skin cancer is the most common type of cancer in America, and in the state of Maine, skin cancer is more common than in most other states. Maine…

December
15
2020

Sensus Healthcare Engages Ekpac Healthcare Ltd. as New Exclusive Distributor in China for SRT-100™ Systems

Agreement is for the treatment of non-melanoma skin cancer and keloids, covers China and Hong Kong and is effective January 1, 2021 BOCA RATON, Fla., Dec. 15, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a…

December
08
2020

Sensus Healthcare Announces CMS Sets Rates Higher for SRT Reimbursement

Centers for Medicare & Medicaid Services sets a 66% increase in reimbursement for Radiation Treatment Delivery code 77401, and increases related Evaluation & Management codes Rates to go into effect as of January 1, 2021…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy